GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,632.00p
   
  • Change Today:
      4.00p
  • 52 Week High: 1,671.50
  • 52 Week Low: 1,264.00
  • Currency: UK Pounds
  • Shares Issued: 4,064.03m
  • Volume: 4,204,808
  • Market Cap: £66,325m
  • RiskGrade: 129

Latest ShareCast News

GSK shingles vaccine approved for expanded use in China

By Benjamin Chiou

Date: Tuesday 14 Oct 2025

(Sharecast News) - Pharma giant GSK has received regulatory approval in China to expand the use of its Shingrix shingles vaccine, the company announced on Tuesday.

GSK ShareCast News

London midday: UK stocks keep grinding towards y... 03-Oct-2025 ShareCast
Emma Walmsley to step down as chief executive of... 29-Sep-2025 ShareCast
Trump to impose tariffs of 100% on branded drug ... 26-Sep-2025 ShareCast
GSK plans $30bn US investment as pharma faces ta... 17-Sep-2025 ShareCast
GSK gepotidacin edges closer to landmark approva... 11-Aug-2025 ShareCast

GSK Regulatory News

Director/PDMR Shareholding 16-Oct-2025 15:30 RNS
Transaction in Own Shares 16-Oct-2025 07:00 RNS
Director/PDMR Shareholding 15-Oct-2025 15:30 RNS
Transaction in Own Shares 15-Oct-2025 07:00 RNS
GSK receives expanded Shingrix approval in China 14-Oct-2025 07:00 RNS

GSK Newspaper Links

GSK boss Emma Walmsley to receive benefits for y... 06-Oct-2025 Times
GlaxoSmithKline scraps sale of old drugs 05-Dec-2014 Telegraph
Glaxo sharpens axe to save £1bn as insurers and ... 01-Dec-2014 The Independent
GSK to cut hundreds of US jobs 01-Dec-2014 Telegraph
Ebola vaccine trials 'encouraging', says GSK 27-Nov-2014 Telegraph

GSK Tips & Analysis

Questor :GlaxoSmithKline 16-Apr-2014 Telegraph
Questor:GlaxoSmithKline 06-Oct-2011 Telegraph
Questor:GlaxoSmithKline 11-Aug-2011 Telegraph
Questor tip: GlaxoSmithKline 28-Jul-2011 Telegraph
Investment Column: GlaxoSmithKline 27-Jul-2011 The Independent

GSK News Wires

FDA Approves Promacta(R) (Eltrombopag), the Firs... 20-Nov-2008 PR Newswire
Study Found That Long Term Use of Advair Diskus(... 29-Oct-2008 PR Newswire
GlaxoSmithKline to Acquire Genelabs Technologies... 29-Oct-2008 PR Newswire
A New Interactive Consumer Experience Highlighti... 28-Sep-2007 PR Newswire
AUDIO from Medialink and GlaxoSmithKline: A New ... 28-Sep-2007 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,632.00p
Change Today 4.00p
% Change 0.25 %
52 Week High 1,671.50
52 Week Low 1,264.00
Volume 4,204,808
Shares Issued 4,064.03m
Market Cap £66,325m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average
36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 3
Buy 3
Neutral 14
Sell 3
Strong Sell 0
Total 23
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q2 Q1
Ex-Div 14-Aug-25 15-May-25
Paid 09-Oct-25 10-Jul-25
Amount 16.00p 16.00p

Trades for 16-Oct-2025

Time Volume / Share Price
15:32 1 @ 1,632.50p
15:32 0 @ 1,632.00p
15:31 0 @ 1,632.00p
15:31 449 @ 1,632.00p
15:31 3,790 @ 1,632.00p

GSK Key Personnel

CEO Emma Walmsley

Top of Page